Literature DB >> 31571277

Dyskinesia-inducing lead contacts optimize outcome of subthalamic stimulation in Parkinson's disease.

Walid Bouthour1,2, Matthieu Béreau1, Astrid Kibleur1, André Zacharia1, Emilie Tomkova Chaoui1, Vanessa Fleury1, Damien Benis1, Shahan Momjian3, Julien Bally1, Christian Lüscher1,2, Paul Krack1, Pierre R Burkhard1.   

Abstract

BACKGROUND: Acute dyskinesias elicited by STN-DBS, here referred to as stimulation-induced dyskinesias, predict optimal clinical outcome in PD. However, it remains elusive whether stimulation-induced dyskinesias can guide DBS programming.
OBJECTIVES: Here, we characterized stimulation-induced dyskinesias clinically and anatomically. We then tested whether dyskinesia-inducing contacts could be effectively programmed using independent current source technology.
METHODS: We characterized stimulation-induced dyskinesias with directional and ring stimulation retrospectively in 20 patients. We then localized dyskinesia-inducing contacts by imaging coregistration and eventually programmed those contacts.
RESULTS: We elicited dyskinesias in half of our patients. Dyskinesia-inducing contacts were mainly directional and were all located ventrally within the dorsolateral motor STN. When these dyskinesia-inducing contacts were programmed using independent current source technology, dyskinesia disappeared and robust antibradykinetic effects were obtained.
CONCLUSION: We confirm that stimulation-induced dyskinesias are helpful clinical observations, which may guide programming of directional STN-DBS in PD.
© 2019 International Parkinson and Movement Disorder Society. © 2019 International Parkinson and Movement Disorder Society.

Entities:  

Keywords:  Parkinson's disease; deep brain stimulation; directional; stimulation-induced dyskinesia; subthalamic nucleus

Mesh:

Year:  2019        PMID: 31571277     DOI: 10.1002/mds.27853

Source DB:  PubMed          Journal:  Mov Disord        ISSN: 0885-3185            Impact factor:   10.338


  1 in total

1.  Target Selection of Directional Lead in Patients with Parkinson's Disease.

Authors:  Ayaka Sasagawa; Rei Enatsu; Mayumi Kitagawa; Takeshi Mikami; Chie Nakayama-Kamada; Tomoyoshi Kuribara; Tsukasa Hirano; Masayasu Arihara; Nobuhiro Mikuni
Journal:  Neurol Med Chir (Tokyo)       Date:  2020-11-06       Impact factor: 1.742

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.